abstract |
Provided are compositions and methods resulting in improved multivalent vaccines. A first set of synthetic nanocarriers comprising a first set of surface antigens, a second set of synthetic nanocarriers comprising a second set of surface antigens, and a pharmaceutically acceptable excipient. A composition comprising a dosage form comprising: an agent, wherein the first set of surface antigens and the second set of surface antigens are structurally different. [Selection figure] None |